Jerusalem Pharmaceuticals financials at a glance
| Year | Year | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
0.00M | 0.00M | 0.00M | 14.09M | 18.07M | 22.02M | 23.73M | 25.84M | 25.61M | 29.79M | 30.80M | 34.09M | 0.00M | 46.23M | 0.00M | 0.00M | 0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 40.92% | 46.01% | 45.13% | 44.67% | 45.26% | 45.55% | 48.79% | 45.94% | 46.53% | 0.00% | 49.30% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 6.54% | 4.62% | 10.71% | 6.65% | 9.35% | 13.39% | 19.02% | 16.75% | 15.24% | 0.00% | 17.27% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | 0.00 | |||||||||||||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
17.06m | 17.06m | 17.06m | 17.06m | 14.22m | 17.06m | 17.06m | 17.06m | 18m | 18m | 18m | 18m | 0m | 18m | 18m | 0m | 0m |
| OCF | Operating Cash Flow |
|
0.00M | 0.00M | 0.00M | 3.17M | 3.52M | 1.06M | 3.71M | 1.85M | 2.48M | 4.75M | 4.34M | 2.38M | 0.00M | 6.05M | 0.00M | 0.00M | 0.00M |
| FCF | Free Cash Flow |
|
0.00M | 0.00M | 0.00M | 0.90M | 0.65M | 0.16M | 2.79M | 0.62M | 1.78M | 3.05M | 2.95M | 0.81M | 0.00M | 3.86M | 0.00M | 0.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
0.00 | 0.00 | 0.00 | 0.08 | 0.04 | 0.01 | 0.16 | 0.04 | 0.09 | 0.15 | 0.11 | -0.01 | 0.00 | 0.21 | 0.00 | 0.00 | 0.00 |